ScreenerHero

TILInstil Bio, Inc.

NAS · US · Healthcare · Biotechnology · instilbio.com
7.580USD+2.57%Mkt Cap: 51.41M $P/E: —

Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with signif…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap51.41M $
Enterprise Value67.74M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-71.37M $
Revenue/Share—
Last Price7.580 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees17
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.51
PEG—
EV/EBITDA-1.85
EV/Revenue—
P/S—
P/B0.46
EPS (TTM)-4.40
EPS (Forward)-14.64
52W Range
5.6707% of range33.83
52W High33.83 USD
52W Low5.670 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-62.68%
ROA-35.07%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-36.62M $
CapEx (TTM)10.00M $
FCF Margin—
FCF Yield166.33%
Net Debt17.35M $
Net Debt/EBITDA-0.47
Balance Sheet
Debt/Equity0.75
Current Ratio21.67
Quick Ratio21.08
Book Value/Sh16.32 USD
Cash/Share10.27 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateDec 8, 2023
Analyst Consensus
Rating—
Target (Mean)7.000 USD
Upside (mean)-7.7%
Target Range7.000 USD – 7.000 USD
# Analysts1
Ownership
Shares Out.6.78M
Float3.62M
Insiders6.56%
Institutions62.50%
Short Interest
Short Ratio15.6d
Short % Float4.70%
Short % Out.2.79%
Shares Short189.16K
Short (prev mo.)234.77K
Technical
SMA 507.485 (+1.3%)
SMA 2008.845 (-14.3%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)10.09K
Avg Vol (10d)6.30K
Technical Indicators
RSI (14)58.7
MACD-0.0126
MACD Signal-0.0536
MACD Hist.+0.0410
BB Upper7.564 USD
BB Middle7.301 USD
BB Lower7.039 USD
BB Width7.19%
ATR (14)0.2093 USD
Vol Ratio (20d)1.00x